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Abstract
Cystathionine beta synthase (CBS) is the rate-limiting enzyme responsible for the de novo synthesis of cysteine. Patients with
CBS deficiency have greatly elevated plasma total homocysteine (tHcy), decreased levels of plasma total cysteine (tCys), and
often a marfanoid appearance characterized by thinness and low body-mass index (BMI). Here, we characterize the growth
and body mass characteristics of CBS deficient TgI278T Cbs
2/2 mice and show that these animals have significantly
decreased fat mass and tCys compared to heterozygous sibling mice. The decrease in fat mass is accompanied by a 34%
decrease in liver glutathione (GSH) along with a significant decrease in liver mRNA and protein for the critical fat
biosynthesizing enzyme Stearoyl CoA desaturase-1 (Scd-1). Because plasma tCys has been positively associated with fat
mass in humans, we tested the hypothesis that decreased tCys in TgI278T Cbs
2/2 mice was the cause of the lean phenotype
by placing the animals on water supplemented with N-acetyl cysteine (NAC) from birth to 240 days of age. Although NAC
treatment in TgI278T Cbs
2/2 mice caused significant increase in serum tCys and liver GSH, there was no increase in body fat
content or in liver Scd-1 levels. Our results show that lack of CBS activity causes loss of fat mass, and that this effect appears
to be independent of low serum tCys.
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Introduction
Cystathionine beta synthase (CBS) is the key regulatory enzyme
for the transsulfuration pathway, which is responsible for the
conversion of methionine to cysteine. The enzyme catalyzes the
condensation of homocysteine with serine to create cystathionine,
the precursor of cysteine. Cysteine is the rate-limiting amino acid
in the biosynthesis of the major intracellular anti-oxidant thiol
glutathione (GSH). In serum cysteine exists mostly in an oxidized
state, cross-linked either to cysteine in proteins or other thiol
containing amino acids. The sum total of all cysteine forms is
known as total cysteine (tCys). CBS deficiency (also known as
classical homocystinuria) is the most common inborn error of
sulfur metabolism and is characterized by extreme elevations of
plasma total homocysteine (tHcy) and methionine along with low
levels of plasma tCys [1]. Patients with CBS deficiency suffer from
a variety of pathologies including thrombosis, osteoporosis, fatty
liver, mental retardation, and dislocated lenses. Interestingly, the
appearance of CBS deficient patients often resembles that of
individuals with Marfan syndrome, characterized by arachnodac-
tyly, scoliosis, low BMI, and reduced fat [2,3].
The relation between CBS deficiency and reduced fat has not
been explored. One possible connection comes from studies
relating tCys and BMI. Epidemiologic data from several thousand
individuals show that tCys is positively associated both BMI and
fat mass [4,5]. Rats on a low methionine diet show significant
increases in both total weight and fat mass when the diets are
supplemented with cysteine [6]. Mice homozygous for mutations
in the glutathione catabolic enzyme gamma-Glutamyl transpep-
tidase have low plasma free cysteine levels (20% of control) and
decreased body mass. Importantly, addition of the cysteine
analogue N-acetylcysteine (NAC) to the drinking water of these
animals results in dramatic increase in overall body weight [7].
Based on these observations, it has been hypothesized that low
serum tCys levels may be the cause of leanness in CBS deficiency
[4].
Our lab has previously developed a mouse model for CBS
deficiency, Tg-I278T Cbs
2/2 [8]. These mice contain a homozy-
gous deletion of the endogenous mouse Cbs gene, and also have a
mutant human CBS gene containing the I278T point mutation
under control of the zinc inducible metallothionein promoter. The
mutant I278T CBS protein is enzymatically crippled, but can
rescue the neonatal lethality associated with the Cbs
2/2 genotype.
Tg-I278T Cbs
2/2 animals have extremely elevated tHcy levels
(,250 mM), low tCys, and survive into adulthood at .90%
efficiency. These animals have several phenotypes including small
size, facial alopecia, osteoporosis, and a 20% shortening of median
and maximal life-span [9].
In the present study, we have performed detailed growth and
body mass composition studies on TgI278T Cbs
2/2 mice and show
that these animals have significantly reduced body fat compared to
sibling controls. We also have investigated the expression of
central lipogenic gene, Stearoyl CoA desaturase-1 (Scd-1) in livers
of CBS deficient TgI278T Cbs
2/2 mice. Finally, to test our
hypothesis that serum tCys is the cause of fat loss, we raised the
serum tCys in the TgI278T Cbs
2/2 mice by addition of N-acetyl
cysteine (NAC) to the animals drinking water.
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Mouse model
Mice used in the study are from C57BL6 strain background.
TgI278T Cbs
2/2 mice were originally created as described
previously [8]. TgI278T Cbs
2/2 mice were generated mating
either transgene positive Cbs
2/2 or Cbs
+/2 male with a transgene-
positive Cbs
+/2 female, in a cage with drinking water containing
25 mM of ZnCl2. Control animals for all experiments were sibling
transgene positive Cbs
+/2 animals. Pups were genotyped on 10
th
day for both the transgene and the Cbs knockout allele, as
described previously [10]. Pups were weaned at 30
th day and then
placed in cages with non-ZnCl2-supplemented water for long-term
weight and photography studies. The cohorts of animals were
weighed and photographed every 30
th day starting from day 30 to
day 420 of their age. Animals were fed standard rodent chow
(Teklad 2018SX; Harlan Teklad, Madison, WI, USA) ad libitum.
All studies were approved by the Fox Chase Cancer Center
IACUC (#99-26).
N-acetyl cysteine (NAC) intervention
Treatment groups had N-acetyl L-cysteine (NAC) dissolved in
their drinking water to a final concentration of 40 mM and were
treated from birth through 240 days. Parents of treated as well as
untreated group were on zinc water during mating and pregnancy.
NAC water was prepared fresh from the chemical (Catalog No#
A9165; Sigma, St. Louis, MO, USA) and was replaced once a
week. Quantitation of NAC stability using a Biochrom 30 amino
acid analyzer indicated that after one week at room temperature,
64% of the NAC was still present. Mice were weighed every 30
th
day starting from day 60 to day 240, at which time the mice were
sacrificed. The liver, kidney and serum were then extracted, and
the tissues and mouse corpses were then stored at 280uC for
further analysis and DEXA studies.
We measured the effect of NAC on food and water intake as
follows. Three Tg-I278T Cbs
+/2 mice (2–3 months old) were kept
per cage (2 cages per sex) with sufficient pre-weighed rodent chow
and either pre-measured regular water or NAC water and
followed for 6 weeks. Mice were allowed to acclimatize with their
respective waters for one week before measurements were taken.
Food and water consumption was calculated weekly by subtracting
the remaining water and food from the starting material after
adjusting for spilled food and water leakage. Spilled food was
collected by using a manual sieve that could separate food particles
from cage bed and mouse excreta. Water leakage was measured by
putting the water bottle in the cages without mice and measuring
the remainder every week.
Dual energy X-ray absorptiometry (DEXA) studies
DEXA analysis was performed using a Lunar PIXimus II
Densitometer (GE, software version 2.0, Lunar Corp., Madison
WI) instrument located in the lab of Dr. Michael Tordoff at
Monell Chemical Senses Center, Philadelphia, PA, USA. The
mice were thawed prior to doing DEXA and results were obtained
in terms of fat mass (FM; g), lean mass (LM; g), total tissue weight
(FM+LM), % Fat [(FM/FM+LM)*100], bone mineral content
(BMC; g) and bone mineral density (BMD; g/cm
2).
Amino acid analysis
Serum tHcy, tCys and other amino acids were measured using
the Biochrom 30 amino acid analyzer (Cambridge, UK) as
previously described [11]. In brief, 50 ml of serum was treated with
5 ml of 12% dithiothreitol (Room temperature; 5 min) followed by
the addition of 55 ml of 10% sulfosalicylic acid. After incubation of
1 h at 4uC the centrifugation was done at 13, 000 rpm for 15
minutes at 4uC. The clear supernatant was used for amino acid
measurement. tCys refers to the sum total of all forms of cysteine,
including protein-bound, free-reduced, and free-oxidized includ-
ing mixed disulfides. Similarly tHcy refers to sum total of all forms
of homocysteine (protein bound, free-reduced and free-oxidized
including mixed disulfides).
Glutathione analysis
A 10% homogenate of liver tissue was made in 2.5%
sulfosalicylic acid at 4uC by employing a manual glass dounce
homogenizer. The homogenate was kept at 4uC for 30 minutes
followed by centrifugation at 10,000 rpm for 15 minutes. The clear
supernatant was used for the quantification of free reduced form of
glutathione (GSH) by employing Biochrom 30 amino acid
analyzer.
Taqman quantitative reverse transcriptase-polymerase
chain reaction (qRT-PCR)
RNA was extracted from the livers using the TRIzol Reagent
(Invitrogen, Carlsbad, CA, USA) followed by cleaning and
removal of contaminating DNA using the RNeasy Mini Kit
(Qiagen, Valencia, CA, USA). Quality of RNA was determined
using an Agilent 2100 bioanalyzer (Agilent Technologies, Santa
Clara, CA, USA) and quantification was done by NanoDrop.
One-step qRT-PCR was done employing Taq Man Gene
expression assays (Applied Biosystems, Foster City, CA, USA)
for mouse Scd-1 (Mm00772290_m1). Mouse beta actin
(Mm01205647_g1) was used as endogenous control. Quantifica-
tion of signal was achieved by using Applied Biosystems 7900 HT
version 2.2.2 sequence detection system. Each sample was assayed
in singlet (100 ng/well) for each gene, and relative signal strength
was calculated using the DDCt method.
Western Blotting
Homogenates (20% w/v) of liver, kidney, spleen, visceral white
adipose (from gonadal region) and subcutaneous white adipose
tissues were prepared at 4uC in RIPA buffer (Thermo Scientific,
USA) containing protease inhibitor cocktail tablet (Complete mini,
Roche, Germany). Homogenates were then put on ice for one
hour before centrifugation at 13, 000 rpm (4uC) for 15 minutes
and supernatant was used for further analysis. Protein concentra-
tion was determined by using BCA protein assay kit (Thermo
Scientific). For Western blotting, 30 mg of total protein extract was
electrophoresed on a 10% Bis tris SDS Polyacrylamide gel
(Invitrogen, USA) using MOPS running buffer (Invitrogen)
followed by transfer on to a PVDF membrane (Bio Rad, USA).
Scd-1 was detected by using a goat polyclonal antibody (1:200; sc-
14719) and secondary anti-goat antibody (1:5,000; sc-2020;
Horseradish peroxide conjugated) from Santa Cruz Biotechnolo-
gy. Signal was visualized by using Supersignal west pico
chemiluminescent kit (Thermo Scientific) and Alpha Innotech
image analyser.
Statistical Analysis
For comparison of two samples, a two-sided unpaired students t-
test was used with P,0.05 being considered significant. For
multiple group comparison one-way ANOVA was done followed
by Tukey’s multiple comparison test using GraphPad Prism 4.0
software (Graphpad Software, La Jolla CA).
Fat Loss in CBS Deficient Mice
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TgI278T Cbs
2/2 mice weigh less and have age-related
hair loss
A cohort of CBS deficient TgI278T Cbs
2/2 mice and TgI278T
Cbs
+/2 sibling controls were weighed and photographed at 30 day
intervals from 30 to 420 days of age. Both male and female TgI278T
Cbs
2/2 mice appeared smaller and weighed significantly less as
compared to age and gender matched control mice at all the times-
tested ages(Fig.1 and Fig.2).Interestingly,the difference in size between
control and Tg-I278T Cbs
2/2 mice increased over time, primarily
because Tg-I278T Cbs
2/2 mice stopped putting on weight after 150
days, while the control animals kept growing throughout the entire
period. We also found that the onset of the facial alopecia phenotype
was between 105 and 120 days of age, and often this alopecia would
spread to the backs of the animals as they continued to age.
Figure 1. Comparison of the weight of CBS deficient TgI278T Cbs
2/2 mice with age and gender matched control TgI278T Cb
+/2 mice.
Between eight and twenty mice were weighed at each time point. Graphs show the mean 6 95% confidence interval (CI). Significance between each
age is shown by unpaired t test (*p,0.05; **p,0.01; ***p,0.001).
doi:10.1371/journal.pone.0027598.g001
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2/2 mice have reduced fat mass compared to
control mice
Dual energy X-ray absorptiometry (DEXA) analysis was
performed on a subset of Tg-I278T Cbs
2/2 and control animals
when they reached 240 days of age (8 months old). DEXA allows
the quantitation of overall fat mass, lean mass, and bone density.
In both male and female Tg-I278T Cbs
2/2 mice there was an
appreciable decrease in fat mass (Fig. 3A, regular water) and
percentage body fat (Fig. 3C; regular water) as compared to
control animals. In male mice the fat mass was decreased from
12.2863.78 g to 4.6860.41 g (P,0.001), while in female mice it
showed the same trend decreasing from 7.9665.25 g to
4.2660.36 g, although the difference here was not statistically
significant (P=0.152). In contrast, the amount of lean mass in Tg-
I278T Cbs
2/2 animals was only slightly affected (9% and 14% less
in females and males respectively, see Fig. 3B; regular water).
These findings indicate that most of the size difference between
Tg-I278T Cbs
2/2 and control animals was due to difference in the
animals fat mass.
In addition, the DEXA analysis confirmed our earlier
observation using micro CT [9] that Tg-I278T Cbs
2/2 mice had
osteoporosis as evidenced by decreased bone mineral density. We
found that the mean bone mineral density was reduced
significantly in both male and female Tg-I278T Cbs
2/2 mice
compared to controls (Fig. 3D; regular water).
Decreased levels of serum cysteine and liver glutathione
Since human studies have suggested that serum tCys may play a
role in regulating fat mass, we measured serum tCys in Tg-I278T
Cbs
2/2 and control mice. Serum tCys was found to be 64%
decreased in Tg-I278T Cbs
2/2 mice as compared to controls
(P,0.001; Fig. 4A; regular water). Consistent with this observa-
tion, we found that liver glutathione levels were 34% decreased in
Tg-I278T Cbs
2/2 mice (P,0.01; Fig. 4B; regular water). These
findings show that lack of CBS activity lowers in vivo cysteine and
glutathione levels despite the presence of cysteine in the diet.
Reduced expression of Scd-1 in Tg-I278T Cbs
2/2 mice
Previously we had performed microarray analysis on liver
mRNA from Tg-I278T Cbs
2/2 and control animals [11]. We
reexamined this data to look specifically at genes known to be
involved in lipogenesis and fatty acid biosynthesis. Table S1 show
the relative expression of these genes in Tg-I278T Cbs
2/2 in
comparison to control mice. The transcript in this group with the
greatest magnitude of change was Scd-1, with a seven-fold
reduction in Tg-I278T Cbs
2/2 animals. Scd-1 encodes the enzyme
Stearoyl-coenzyme A desaturase, key lipogenic enzyme catalyzing
the synthesis of monounsaturated fatty acids, mainly oleate and
palmitoleate [12]. To confirm that Scd-1 was indeed down-
regulated in Tg-I278T Cbs
2/2, we performed quantitative real
time PCR on Tg-I278T Cbs
2/2 mice and age and sex matched
controls (Fig. 5A; regular water). Our results showed that
expression of liver Scd-1 message was only 6% of that observed
in control animals (P,0.001). We also observed a 54% reduction
in liver SCD-1 protein levels (Fig. 5B; regular water). We did not
see any reduction SCD-1 levels in either of two white adipose
tissues examined (Fig. 5C).
NAC treatment does not reverse phenotypes in Tg-I278T
Cbs
2/2 mice
We next tested the hypothesis that the low levels of serum tCys
and tissue glutathione levels might be responsible for the loss of fat
mass and other phenotypes exhibited by Tg-I278T Cbs
2/2 mice.
N-acetyl-L-cysteine (NAC), a cysteine analog, was added to the
drinking water of both Tg-I278T Cbs
2/2 and control mice at a
concentration 40 mM at the time of birth. We then measured
weight at 60, 90, 105, 120, 150, 180, 210, and 240 days of age. We
found that at all of the time points the average weight of NAC
treated Tg-I278T Cbs
2/2 mice was less than NAC treated control
animals (see Fig. 6 A,B). However, the relative difference in weight
between the two genotypes was less than when the mice were on
regular water (Fig. 1). The cause of this decrease in the difference
became clear when we compared weights of mice on regular water
vs. NAC water. We found that both control and Tg-I278T Cbs
2/2
animals exhibited reduced weights at each time point when on
NAC water, but this difference was greater in control animals
compared to Tg-I278T Cbs
2/2, especially as the animals aged
(Fig. 6C). We also failed to observe any effect of NAC treatment
on the reversing or delaying the alopecia phenotype in Tg-I278T
Cbs
2/2 animals (Fig.S1A,B).
When the animals were 240 days old, DEXA analysis was
performed on the NAC treated cohort. We observed large
statistically significant decreases in fat mass, lean mass, percentage
body fat, and bone mineral density in control animals on regular
Figure 2. Photographic and weight comparison of a pair of
sibling male TgI278T Cbs
2/2 and TgI278T Cbs
+/2 mice ranging
from 60 to 240 days of age. Mice photographed from 60d-240d are
the exact same pair. The TgI278T Cbs
2/2 animal in each pair is indicated
by the arrow.
doi:10.1371/journal.pone.0027598.g002
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2/2 and TgI278T Cbs
+/2 mice on regular and NAC supplemented
water. All panels show effects on male and female animals separately. (A) Effect of genotype and NAC treatment on fat mass. (B) Effect of genotype
and NAC treatment on lean mass. (C) Effect of genotype and NAC treatment on percentage of fat. (D) Effect of genotype and NAC on bone mineral
density. Significance testing was performed using ANOVA followed by Tukey’s multiple comparison test. All graphs show mean 6 SD. Significant
difference between columns are indicated by having a different letter at the top of the error bar. In case of more than two letters, even a single
common letter at the top of the bar indicates non-significance.
doi:10.1371/journal.pone.0027598.g003
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2/2
animals were much less severely affected, with significant
differences observed in lean, fat mass, and bone mineral density
only in female animals. Finally, we examined Scd-1 expression in
NAC treated animals by both quantitative RT-PCR and Western
analysis. We did not observe significant changes in the levels of
Scd-1 in either Tg-I278T Cbs
2/2 or control animals. (Fig. 5A,B;
NAC water).
In summary these studies, in contrast to our a priori expectation,
show that addition of NAC to drinking water did not restore fat
mass or bone density to Tg-I278T Cbs
2/2 animals.
NAC treatment elevates tCys and liver glutathione in Tg-
I278T Cbs
2/2 mice
Because NAC did not improve the phenotypes of Tg-I278T
Cbs
2/2 mice, we examined if oral NAC was effective in raising
serum tCys and liver glutathione. We found that in Tg-I278T
Cbs
2/2 mice, tCys raised by 50%, from 101.7 to 152.6 mM
(p,0.001, Fig. 4A). In contrast, we failed to observe any significant
change in between NAC treated and untreated control mice (281
vs 261 mM, P=ns). Interestingly serum tHcy levels were slightly
lower in NAC treated Tg-I278T Cbs
2/2 mice compared to
untreated mice (383.6 vs. 334.5 mM, P,0.05). Amino acid
profiling of twenty-seven additional amino acids and amine
containing compounds did not reveal any other statistically
significant changes (Table S2).
Since cysteine is the rate limiting amino acid in glutathione
biosynthesis and in liver approximately 50% of the cysteine in
glutathione is derived from methionine via transsulfuration
pathway [13], we determined if liver GSH levels were modulated
by NAC treatment (Fig. 4B). Like tCys, we found that NAC
treatment raised liver GSH levels in Tg-I278T Cbs
2/2 animals,
but had no effect on control animals. These experiments show that
NAC treatment did have the desired physiological effects of raising
tCys and liver glutathione in Tg-I278T Cbs
2/2 mice, but did not
cause an increase in control animals.
Effect of NAC treatment on Food and water consumption
Because of the large decrease in weight and fat mass in control
(Tg-I278T Cbs
+/2) on NAC water, we performed a 6 week study to
Figure 4. Effect of CBS genotype and NAC treatment on serum total cysteine and liver GSH. (A) Serum tCys. (B) Liver GSH. All four groups
include 5 male and 5 female animals that were measured at 240 days of age. Graphs show the mean 6 SD. Having different letters at the top of the
error bar indicates significant differences between columns.
doi:10.1371/journal.pone.0027598.g004
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twelve week old mice. We found that although NAC added to the
water decreased the water intake by around 40%, the food intake
was only 10% less compared to mice on regular water (Fig.
S2A,B). Similar percent reduction was estimated when results were
calculated in terms of consumption/kg body weight/day (data not
shown). However, we also observed that NAC treatment resulted
in a 45% reduction in weight gain (Fig. S2C). These findings
suggest that NAC may be affecting weight gain by means other
than simply decreasing food intake.
Discussion
In this study we have shown for the first time that the decreased
weight of the Tg-I278T Cbs
2/2 mouse model of CBS deficiency is
driven primarily by decreased fat mass. Body composition study by
DEXA reveals that 240 day old TgI278T Cbs
2/2 mice have a 46%
(in females) to 62% (in males) reduction in fat mass than age and
sex matched control animals. On the other hand, lean mass was
only slightly affected (9% and 14% less in females and males
respectively). Our findings integrate well with the observation that
Figure 5. Effect of CBS genotype and NAC treatment on SCD-1 levels. (A) Liver Scd-1 mRNA levels assessed by qRT-PCR. All four groups
include 5 males and 5 females that are exactly 240 days of age. Graphs show the mean 6 SD. Having different letters at the top of the error bar
indicates significant differences between columns; (B) Liver SCD-1 protein levels as assessed by Western blotting. SCD1 runs as a doublet centered at
37 kDa. (C) SCD-1 expression in kidney, spleen, visceral, and subcutaneous fat from (Tg-I278T Cbs
+/2) and Cbs deficient (Tg-I278T Cbs
2/2) mice.
doi:10.1371/journal.pone.0027598.g005
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decreased subcutaneous fat [2,3]. This large decrease in fat mass is
associated with a reduction in mRNA expression and protein
levels of Scd-1, a key enzyme involved in lipogenesis. Scd-1
catalyzes the biosynthesis of unsaturated fatty acids which
promotes obesity [12]. Mice with targeted disruption of Scd-1
have reduced body adiposity, increased insulin sensitivity, and
resistance to diet induced weight gain [14]. Moreover, ob/ob mice
with mutations in Scd-1 are significantly less obese than ob/ob
controls [15]. Interestingly, both Scd-1
2/2 mice and Cbs
2/2 mice
have been noted to have cutaneous abnormalities [16,17,18].
Recently, rats on a methionine restricted diet have been shown to
have both low hepatic Scd-1 levels, and low body fat [6]. Given
these relationships it seems likely that the reduced level of hepatic
Scd-1 expression observed in Tg-I278T Cbs
2/2 mice is at least in
part responsible for the reduction in fat mass.
In this study we have also explored the hypothesis that low
plasma cysteine and tissue GSH resulting from loss of CBS activity
might mediate both the observed fat loss and the down regulation
of Scd-1. The motivation for this hypothesis comes from both
epidemiological studies in humans, as well as dietary manipulation
studies in rodents [4,6,7]. To test this hypothesis, we performed an
intervention study in which we restored tCys by addition of NAC
to the animals’ drinking water. Chemically NAC is similar to
cysteine, but the presence of acetyl moiety make it less susceptible
to oxidation and more soluble in water, thus making it a better
source of cysteine [19]. NAC is widely available as a human
supplement and has been used in a variety of clinical trials to treat
conditions such as bronchitis, cystic fibrosis, and HIV infection
[20,21,22]. Measurements of serum tCys and liver GSH in NAC
treated Tg-I278T Cbs
2/2 mice indicated that the treatment was
successful in raising tCys and liver GSH. Liver GSH levels were
entirely corrected, while serum tCys increased by 50%, although
this was still somewhat lower than in control mice. Based on the
hypothesis that low tCys and liver GSH are the driving force for
the accumulation of fat mass, we expected mice on NAC
intervention to weigh more and have increased fat mass. However,
contrary to our expectation, we observed the opposite effect, i.e.
NAC treated mice showed decreased total weight and fat mass. In
addition, NAC treatment had no significant effect on Scd-1 mRNA
or protein levels and failed to reverse either the osteoporosis or
alopecia phenotypes. In total, our data indicate that low serum
tCys and tissue GSH are not the direct cause of fat mass, hair-loss,
or osteoporosis phenotypes in Tg-I278T Cbs
2/2 mice.
Besides low cysteine, Tg-I278T Cbs
2/2 mice also have greatly
elevated plasma homocysteine levels and liver S-adenosylhomo-
cysteine (SAH levels) [9]. SAH is strong inhibitor of a variety of S-
adenosylmethionine dependent methyltransferase enzymes, in-
cluding DNA and histone methyltransferases [23,24,25,26,27].
Methylation of DNA and histones are critical events in the
regulation of gene expression [28–29]. It is possible that the low
levels of Scd-1 mRNA observed in the livers of Tg-I278T Cbs
2/2
animals may be related to inhibition of specific methyltransferase
enzymes that normally are involved in regulating transcription
from the Scd-1 promoter. Studies examining the chromatin state of
the Scd-1 promoter could confirm if this was in fact the case.
An unexpected finding of this study was that control animals
exhibited a 48–56% (females-males) decrease in fat mass as a result
of being given NAC water. Interestingly, we only observed a slight
decrease in food intake in NAC treated animals, suggesting that
the decrease in fat mass may be related to altered metabolism. It
should be noted that there are several reports linking NAC in
drinking water and weight loss. In one study it was found that
NAC addition to drinking water resulted in decreased weight gain
and BMI in rats on a high sucrose diet [30]. In another study, rats
treated with NAC in drinking water showed significant decreases
in relative body weight and a reduction of visceral fat [31]. The
same study found that NAC inhibited lipid droplet formation in
3T3L1 adipocytes in vitro. Although reactive oxygen species (ROS)
play an important role in adipocyte differentiation of 3T3L1 cells
[32], and mediate insulin dependent signal transduction [33],
other antioxidants including GSH, ascorbic acid and retinoic acid
show no effect in vitro [31]. These results leave open the possibility
that the reason we failed to see increased fat mass accumulation in
Tg-I278T Cbs
2/2 mice treated with NAC is that the pro-lipogenic
effects of elevation in serum cysteine was somehow counteracted
by the anti-oxidant effect of NAC. One key difference between
Figure 6. Comparison of weight of NAC treated TgI278T Cbs
2/2
and TgI278T Cbs
+/2 mice over time. (A) Weights of male mice. (B)
Weights of female mice. (C) Shows the % of regular water weight for
each genotype at each time point. Significance was done by unpaired t
test: *p,0.05; **p,0.01; ***p,0.001; ns (non significant). Graphs show
the mean 6 SD.
doi:10.1371/journal.pone.0027598.g006
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cysteine is not. In the future the difference between NAC and
cysteine could be addressed by altering the cysteine content of the
mouse diet directly.
In summary, we have shown that Tg-I278T Cbs
2/2 mice
lacking CBS activity have decreased serum tCys, decreased liver
GSH, decreased fat mass, facial alopecia, reduced bone mineral
density and more than 90% reduction in liver Scd-1 mRNA
compared to sibling control animals. However, we failed to see any
improvement in these phenotypes when serum tCys and liver
GSH were elevated by feeding the animals NAC for a period of
240 days. Our results suggest that the phenotypes observed in CBS
deficient patients are probably not related to low tCys levels and
reinforce the view that it is the elevated tHcy that is the pathologic
agent in CBS deficiency.
Supporting Information
Figure S1 Effect of NAC treatment on hair loss pheno-
type. Representative pairs of sibling of Tg-I278T Cbs
2/2 and Tg-
I278T Cbs
+/2 mice are shown over the course of 60 to 240 days of
age. Panels on left show pair on regular water, while panels on
right shows a different pair on NAC water.
(PPT)
Figure S2 Effect of NAC treatment on water and food
consumption in Tg-I278T Cbs
+/2 control mice. (A) Water
consuminption is shown for a six week period with the mean 6 SD
from each cage shown. (B) Food consumption is shown. (C) Total
weight gained and total food consumed by NAC treated control
mice compared to regular water control mice in 7 weeks (including
one week of acclimatization). Paired t-test was done for all the
panels.
(PPT)
Table S1 Expression levels of selected lipogenesis
genes. Previously published microarray data from the livers of
Tg-I278T Cbs
2/2 and control mice were analyzed for genes
specifically involved in lipogenesis (see reference [9]).
(DOC)
Table S2 Comparison of serum amino acids in Tg-I278T
Cbs
2/2 on normal and NAC containing water.
(DOC)
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